|
1
|
Solomonson LP, Flam BR, Pendleton LC,
Goodwin BL and Eichler DC: The caveolar nitric oxide
synthase/arginine regeneration system for NO production in
endothelial cells. J Exp Biol. 206:2083–2087. 2003.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Khalaf D, Krüger M, Wehland M, Infanger M
and Grimm D: The effects of oral L-arginine and L-citrulline
supplementation on blood pressure. Nutrients.
11(E1679)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Breuillard C, Bonhomme S, Couderc R,
Cynober L and De Bandt JP: In vitro anti-inflammatory effects of
citrulline on peritoneal macrophages in Zucker diabetic fatty rats.
Br J Nutr. 113:120–124. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Liu Y, Tian X, Gou L, Fu X, Li S, Lan N
and Yin X: Protective effect of L-citrulline against
ethanol-induced gastric ulcer in rats. Environ Toxicol Pharmacol.
34:280–287. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Darabi Z, Darand M, Yari Z, Hedayati M,
Faghihi A, Agah S and Hekmatdoost A: Inflammatory markers response
to citrulline supplementation in patients with non-alcoholic fatty
liver disease: A randomized, double blind, placebo-controlled,
clinical trial. BMC Res Notes. 12(89)2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jintake C, Azuma K and Okamoto Y:
Combination of glucosamine hydrochloride and citrulline for
experimental osteoarthritis model. Chitin Chitosan Res.
25(180)2019.(In Japanese).
|
|
7
|
Largo R, Alvarez-Soria MA, Díez-Ortego I,
Calvo E, Sánchez-Pernaute O, Egido J and Herrero-Beaumont G:
Glucosamine inhibits IL-1beta-induced NFkappaB activation in human
osteoarthritic chondrocytes. Osteoarthritis Cartilage. 11:290–298.
2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Naito K, Watari T, Furuhata A, Yomogida S,
Sakamoto K, Kurosawa H, Kaneko K and Nagaoka I: Evaluation of the
effect of glucosamine on an experimental rat osteoarthritis model.
Life Sci. 86:538–543. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hua J, Sakamoto K, Kikukawa T, Abe C,
Kurosawa H and Nagaoka I: Evaluation of the suppressive actions of
glucosamine on the interleukin-1beta-mediated activation of
synoviocytes. Inflamm Res. 56:432–438. 2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Nagaoka I: Recent aspects of the
chondroprotective and anti-inflammatory actions of glucosamine, a
functional food. Juntendo Med J. 60:580–587. 2014.
|
|
11
|
Ogata T, Ideno Y, Akai M, Seichi A, Hagino
H, Iwaya T, Doi T, Yamada K, Chen ZA, Li Y and Hayashi K: Effects
of glucosamine in patients with osteoarthritis of the knee: A
systematic review and meta-analysis. Clin Rheumatol. 37:2479–2487.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kubomura D, Ueno T, Yamada M and Nagaoka
I: Evaluation of the chondroprotective action of
N-acetylglucosamine in a rat experimental osteoarthritis model. Exp
Ther Med. 14:3137–3144. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shikhman AR, Brinson DC, Valbracht J and
Lotz MK: Differential metabolic effects of glucosamine and
N-acetylglucosamine in human articular chondrocytes. Osteoarthritis
Cartilage. 17:1022–1028. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Shikhman AR, Kuhn K, Alaaeddine N and Lotz
M: N-acetylglucosamine prevents IL-1beta-mediated activation of
human chondrocytes. J Immunol. 166:5155–5160. 2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shikhman AR, Amiel D, D'Lima D, Hwang SB,
Hu C, Xu A, Hashimoto S, Kobayashi K, Sasho T and Lotz MK:
Chondroprotective activity of N-acetylglucosamine in rabbits with
experimental osteoarthritis. Ann Rheum Dis. 64:89–94.
2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Katsuno S, Eguchi C, Yoshimura K, Yamamoto
T, Tomonaga A and Nagaoka I: Effects and safety of milk beverage
contaning N-acetyl glucosamine on knee joint pain and biomarkers of
type II collagen metabolism: Preliminary study on open design. Jpn
Pharmacol Ther. 38:435–445. 2010.
|
|
17
|
Naraoka Y, Harada H, Katagiri M, Yamamura
H and Shirasawa T: N-acetyl glucosamine and proteoglycan containing
supplement improves the locomotor functions of subjects with knee
pain. Drug Discov Ther. 11:140–145. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rafi MM, Yadav PN and Rossi AO:
Glucosamine inhibits LPS-induced COX-2 and iNOS expression in mouse
macrophage cells (RAW 264.7) by inhibition of p38-MAP kinase and
transcription factor NF-kappaB. Mol Nutr Food Res. 51:587–593.
2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ju Y, Hua J, Sakamoto K, Ogawa H and
Nagaoka I: Modulation of TNF-alpha-induced endothelial cell
activation by glucosamine, a naturally occurring amino
monosaccharide. Int J Mol Med. 22:809–815. 2008.PubMed/NCBI
|
|
20
|
Yomogida S, Hua J, Sakamoto K and Nagaoka
I: Glucosamine suppresses interleukin-8 production and ICAM-1
expression by TNF-alpha-stimulated human colonic epithelial HT-29
cells. Int J Mol Med. 22:205–211. 2008.PubMed/NCBI
|
|
21
|
Jenei-Lanzl Z, Meurer A and Zaucke F:
Interleukin-1β signaling in osteoarthritis-chondrocytes in focus.
Cell Signal. 53:212–223. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lin YC, Liang YC, Sheu MT, Lin YC, Hsieh
MS, Chen TF and Chen CH: Chondroprotective effects of glucosamine
involving the p38 MAPK and Akt signaling pathways. Rheumatol Int.
28:1009–1016. 2008.PubMed/NCBI View Article : Google Scholar
|
